Quality and Regulatory

Setting the Standard

Katharina Schlereth, Labor LS

Reigniting PDA Puerto Rico

Justin Johnson, PDA

Navigating the AI Landscape

Peter Makowenskyj, MEng, G-CON Manufacturing and Toni Manzano, PhD, Aizon

Understanding FDA Complete Response Letters

Justin Johnson, PDA

Driving Innovation in Pharma

Antonella Maggio, Lesirg Consultants Inc. , Beth Haas, Haas Pharma Consulting LLC , and Vinny Browning III, Amgen, Inc.

Building Maturity and Resilience Through Quality Culture

Annette Boland, PharmaLex

A New Era for the PDA Journal

PDA JPST Editorial Team

MHRA’s Decentralized Manufacturing Regulation Set to Take Effect

Munyaradzi Japondo, PharmaLex

Accelerating Progress: How PDA Drives AI Innovation in Healthcare

Andrew Chang, Novo Nordisk, et al.

From Warp Speed to Uncertainty: U.S. Vaccine Policy in Crisis

Anya Hillery, PhD, Freelance Medical Writer

The New Normal at the FDA

Katie Bevard, Eli Lilly

News Brief: FDA Cracks Down on Misleading Drug Ads

Justin Johnson, PDA

Teaching the Plant

Abhinav Arora, Curia

FDA Expands Use of Unannounced Foreign Inspections

Louise Uí Fhatharta, Pharmalex

Beyond the Limits

Yanet Flor, GMP Check Solutions

News Brief: FDA Announed FDA PreCheck

Justin Johnson, PDA

News Brief: PDA AI Glossary Now Available

Walter Morris, PDA

News Brief: Sean Keveney Appointed Chief Counsel of FDA

Justin Johnson, PDA

Equivalence Testing of BFPCs in Grade A Environments

Mads Lichtenberg, PhD, Fujifilm Biotechnologies, et. al.

News Brief: FDA Releases 200 Drug Rejection Letters

Justin Johnson, PDA

Planning for a Dual-Method Future

Nora Blair, Charles River

Leading the Turnaround

Troy Chavis, PrecisionPharma Manufacturing Solutions, LLC